arginine has been researched along with Erythremia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davì, G; De Cristofaro, R; Dragani, A; Falco, A; Fioritoni, F; Lattanzio, S; Lessiani, G; Mattoscio, D; Recchiuti, A; Rocca, B; Romano, M; Santilli, F | 1 |
| Hayashi, T; Kaneko, M; Nakao, Y; Nomura, T; Nonaka, Y; Okamura, J; Suyama, Y | 1 |
2 other study(ies) available for arginine and Erythremia
| Article | Year |
|---|---|
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Aspirin; Blood; Case-Control Studies; Colony-Forming Units Assay; Endothelial Cells; Female; Humans; Male; Middle Aged; Polycythemia Vera; Stem Cells; Thromboxane A2; Thromboxane B2; Thromboxanes | 2008 |
Heparin-induced thrombocytopenia and thrombosis in a patient with polycythemia vera.
Topics: Aged; Arginine; Female; Follow-Up Studies; Heparin; Humans; Japan; Pipecolic Acids; Polycythemia Vera; Pulmonary Embolism; Risk Assessment; Severity of Illness Index; Sulfonamides; Thrombocytopenia; Thrombosis; Treatment Outcome | 2004 |